Tryptophan

Tryptophan

SCHEMBL7208880

N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O.[N]N

nearest known ligand 0.94

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.94
▸ KDM4E B2RXH2 3/20 0.94
▸ MAPT P10636 3/20 0.94
▸ LMNA P02545 2/20 0.94
▸ TSHR P16473 2/20 0.94
▸ BLM P54132 2/20 0.94
▸ PMP22 Q01453 2/20 0.94
▸ MEN1 O00255 2/20 0.94
▸ MPO P05164 1/20 0.94
▸ HIF1A Q16665 1/20 0.94
▸ SMN1; SMN2 Q16637 1/20 0.67
▸ APAF1 O14727 1/20 0.65
▸ POLB P06746 1/20 0.65
▸ RECQL P46063 1/20 0.65
▸ L3MBTL1 Q9Y468 1/20 0.65
▸ HTR2A P28223 3/20 0.64
▸ HTR1A P08908 2/20 0.64
▸ HTR2C P28335 2/20 0.64
▸ SLC6A4 P31645 2/20 0.64
▸ HTR7 P34969 2/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dl-Tryptophan SCHEMBL19161120 0.97 KMT2A (1.00) KMT2AKDM4EMAPTLMNATSHR
Dl-Tryptophan SCHEMBL475349 0.97 KMT2A (1.00) KMT2AKDM4EMAPTLMNATSHR
Dl-Tryptophan SCHEMBL4732052 0.97 KMT2A (1.00) KMT2AKDM4EMAPTLMNATSHR
Dl-Tryptophan SCHEMBL289042 0.97 KMT2A (1.00) KMT2AKDM4EMAPTLMNATSHR
Tryptophan SCHEMBL289043 0.97 KMT2A (1.00) KMT2AKDM4EMAPTLMNATSHR
Tryptophan SCHEMBL23141133 0.97 KMT2A (1.00) KMT2AKDM4EMAPTLMNATSHR
Dl-Tryptophan SCHEMBL7327 0.97 KMT2A (1.00) KMT2AKDM4EMAPTLMNATSHR
Tryptophan SCHEMBL475350 0.97 KMT2A (1.00) KMT2AKDM4EMAPTLMNATSHR
Dl-Tryptophan SCHEMBL1120026 0.97 KMT2A (1.00) KMT2AKDM4EMAPTLMNATSHR
Tryptophan SCHEMBL4732053 0.97 KMT2A (1.00) KMT2AKDM4EMAPTLMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0914111-B1 PREVENTION AND TREATMENT OF CACHEXIA AND ANOREXIA ABBOTT LAB (US) 2003-11-19 — — EP claimed
Send feedback